Wockhardt Ltd Major Developments and Expansions

The rally is fueled by clarity on exemptions for Indian pharma exports under new US tariffs effective October 1, 2025, benefiting Wockhardt's Europe-based manufacturing (via acquired Negma in France) and innovative drug focus. Analysts see this as a tailwind amid broader sector concerns.